A 10.8% to 38.4% discount. That's the range Hyperliquid's IPOP markets claimed to find on IPO prices. The problem? Nobody outside the trading pool can verify it. And the SEC is watching.
This isn't a new token launch. It's a comment letter filed by the Hyperliquid Policy Center (HPC) and trade[XYZ]—a response to the SEC's request for input on the regulatory treatment of synthetic assets. They're proposing a framework for Pre-IPO Perpetuals (IPOPs): perpetual contracts that track the price of a company's stock before its IPO. No shares. No delivery. Just a bet on the opening price.
I've been tracking on-chain data since 2018. I've seen projects claim price discovery while hiding the real mechanics. The IPOP proposal is a masterclass in regulatory framing—but the data doesn't hold up to forensic scrutiny. The ledger does not lie, but the CEOs do.
Context: The Players and the Game
Hyperliquid is a self-built L1 for derivatives, now the dominant DEX for perpetuals with over 50% market share. Its ecosystem includes HPC (the policy arm) and trade[XYZ] (a market maker). Together, they launched five IPOP markets, each running from pre-IPO announcement to the first trade on the public exchange. According to their submission, the IPOP prices converged to the IPO opening price with a discount of 10.8% to 38.4%.
The pitch to the SEC: IPOPs provide continuous price discovery, improve market efficiency, and reduce the information asymmetry in the traditional IPO process. They argue that the product is a synthetic asset—not a security—because it grants no rights to the underlying shares. The Howey test? They claim it fails on the 'common enterprise' and 'reliance on others' efforts' prongs.
But the real story is in the architecture. IPOPs are perpetual contracts with a built-in expiration: the IPO date. After that, the contract ceases to exist. The price is anchored by the funding rate mechanism, which forces convergence to the expected IPO price via arbitrage. This is not 'price discovery' in the fundamental sense; it's a mechanical convergence driven by speculators betting on the underwriter's final number.
Core: The Technical Reality and the Data Gap
The Machine Behind the Curtain
IPOPs run on Hyperliquid's L1 order book. The key innovation is not the technology—it's the product structure. The contracts are synthetic: they mirror the value of a stock without any custody or transfer of shares. This sidesteps the need for licensed broker-dealers, but it also creates a critical flaw: there is no underlying asset to anchor the price. The only anchor is the market's expectation of the IPO price, which is itself a function of the underwriter's book-building process.
From my experience in the 2020 DeFi Summer liquidity mining blitz, I learned that synthetic assets can diverge wildly from their reference price if the funding rate mechanism is not calibrated correctly. The IPOP's convergence to IPO price relies on the presence of arbitrageurs who can short the perpetual and buy the expected IPO shares—but those shares don't exist until the IPO. So the convergence is actually a bet on the accuracy of the underwriter's pricing, not a discovery of it.
The 10.8%–38.4% Discount: A Data Dilemma
This is the headline number. A discount that wide suggests the IPO market systematically underprices new listings—a well-known Wall Street phenomenon. But the data comes from only five markets, all operated by the same market maker, trade[XYZ]. The sample size is tiny. The selection bias is obvious: these are the markets that succeeded. What about the ones that failed?
I've been on the other side of this. During the 2022 FTX collapse, I tracked $2 billion in outflows to Alameda wallets hours before the bankruptcy filing. That data was verifiable on-chain. The IPOP data is not. The proposal does not provide raw trade logs, order book snapshots, or funding rate history. Without independent verification, this 'price discovery' claim is just a marketing slide.
Regulatory Translation: The Howey Test and the CFTC-SEC Divide
The submission leans heavily on the argument that IPOPs are not securities. Let's run the Howey test:
- Money investment: Yes. Users put capital into the perpetual.
- Common enterprise: No. The pool is not a joint venture; it's just a market.
- Expectation of profits: Yes. Traders enter to profit from price movements.
- Profits from efforts of others: No. The price is determined by market supply and demand, not by the promoter's efforts.
At first glance, it fails Howey. But the SEC has a history of applying a flexible interpretation. The critical question is whether IPOPs constitute a 'security-based swap' under the Securities Exchange Act. The SEC has argued that any derivative that references a security can be regulated as a security itself. The IPOP's price is directly tied to the stock's IPO price—making it a de facto security derivative.
Furthermore, the CFTC would likely claim jurisdiction if IPOPs are classified as 'event contracts' under the Commodity Exchange Act. The prediction market Polymarket operates under CFTC oversight via a no-action letter. But Polymarket's contracts are binary: yes/no outcomes. IPOPs are continuous, and they reference a single security's price. That's a red flag for both agencies.
Market Impact: The Liquidity and Manipulation Risk
If the SEC accepts the proposal, Hyperliquid becomes the first DEX to offer regulated pre-IPO derivatives. That would attract institutional capital and increase HYPE token demand. But the road is treacherous.
Currently, Hyperliquid does not require KYC for US users. The proposal acknowledges 'accessibility for US investors' as a key issue. If the SEC determines that IPOPs are securities, Hyperliquid would need to geofence US IPs and implement KYC/AML. That would drain liquidity and fragment the order book.
Even without regulatory action, the market structure is fragile. Trade[XYZ] is the sole market maker for all five IPOP markets. That's a single point of failure. In a volatile pre-IPO period, a market maker's withdrawal could cause a liquidity crisis and distort the price signal. The SEC cares about 'market integrity'—and a single market maker running a price discovery market is the opposite of integrity.
Contrarian: The Unreported Angle—IPOPs Are a Casino, Not a Discovery Engine
The traditional IPO process is a carefully orchestrated dance between the issuer, underwriters, and institutional investors. The underwriter sets a price range, gauges demand, and allocates shares. The IPO discount is a feature, not a bug—it ensures a 'pop' on the first day, rewarding early investors and maintaining demand.
IPOPs create a parallel market that can influence this process. If the perpetual price consistently trades below the expected IPO price, it signals that the underwriter's pricing is too high. But the IPOP price is not a reflection of fundamental value; it's a reflection of speculators' expectations of the underwriter's price. This is circular: the market is betting on the IPO price, which is itself set by the underwriter based on demand. The IPOP becomes a meta-bet on the book-building process, not on the company's value.
Worse, the lack of delivery means that IPOP traders have no skin in the game regarding the company's long-term prospects. They can manipulate the perpetual price through coordinated short selling, creating a false signal that could influence the IPO pricing. The SEC has a mandate to protect retail investors from market manipulation. A derivative market that can influence the price of a primary offering is a regulatory nightmare.
Intermediaries are just slow nodes in the network. Hyperliquid's L1 is fast, but it replaces the slow node of the underwriter with the fast node of a single market maker. That's not decentralization; it's centralization with lower latency.
Takeaway: The SEC Will Demand a Trade-Off
The IPOP proposal is a clever regulatory gambit. It positions Hyperliquid as a constructive player, willing to engage with the SEC. But the data is weak, the market structure is fragile, and the product sits in a regulatory no-man's land.
Expect the SEC to respond with a request for more data—trading logs, independent audits, and a detailed explanation of how the funding rate mechanism ensures price integrity. They may also ask for a demonstration of how IPOPs comply with the federal securities laws.
The real question is not whether this is legal. It's whether Hyperliquid is willing to become a regulated entity. If yes, the casino gets a license. If no, the party ends at the US border. Volatility is the price of admission, not the exit.
Watch for the next SEC filing. The clock is ticking.